Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01341067 · ClinicalTrials.gov registry record
Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes
A clinical trial of Type 2 Diabetes Mellitus, sponsored by Rocky Mountain Diabetes and Osteoporosis Center.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT01341067: Completed study of Type 2 Diabetes Mellitus, sponsored by Rocky Mountain Diabetes and Osteoporosis Center.
NCT01341067 is a study of Type 2 Diabetes Mellitus that has completed, run by Rocky Mountain Diabetes and Osteoporosis Center. The registered enrollment target is 30 participants, below the 2,960-participant average among 130 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01341067, a study of Type 2 Diabetes Mellitus, has completed, sponsored by Rocky Mountain Diabetes and Osteoporosis Center.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the effect CGM (continuous glucose monitoring) has on subjects with type 2 diabetes. It is anticipated that patients using the device will obtain tighter control of their blood sugars resulting in measureable health benefits and improved confidence in their ability to manage their diabetes.
Conditions Studied
Study Locations (1)
Idaho
- Rocky Mountain Diabetes and Osteoporosis Center - Idaho Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-04 |
| Est. Completion | 2011-12 |
What the finished NCT01341067 record still lists
NCT01341067 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 2,960-participant average among 130 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 0 interventions.
NCT01341067 reports a single indexed study location in Idaho.
Frequently Asked Questions
What is clinical trial NCT01341067 about?
NCT01341067 is a clinical study titled "Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes". The purpose of this study is to examine the effect CGM (continuous glucose monitoring) has on subjects with type 2 diabetes. It is anticipated that patients using the device will obtain tighter control of their blood sugars resulting in measureable health benefits and improved confidence in their ab...
What is the current status of trial NCT01341067?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2011-04. Estimated completion is 2011-12.
What conditions does trial NCT01341067 study?
This clinical trial studies the following conditions: Type 2 Diabetes Mellitus.
Who is sponsoring clinical trial NCT01341067?
This trial is sponsored by Rocky Mountain Diabetes and Osteoporosis Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01341067 being conducted?
This trial has 1 study location across Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01341067's enrollment target sits among peer trials
30 91st of 130 higher than 37 of 130 other Type 2 Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System
RECRUITING
-
A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus
RECRUITING · Phase 1
-
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
RECRUITING
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
RECRUITING
-
A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia